Esperion Announces Two Data Presentations of NEXLETOL® (bempedoic acid) Tablet at the ESC Congress 2020GlobeNewsWire • 08/26/20
Esperion Therapeutics, Inc. (ESPR) CEO Tim Mayleben on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/11/20
Esperion Reports Second Quarter 2020 Financial Results and Provides Company UpdateGlobeNewsWire • 08/10/20
Esperion Therapeutics Scores Relative Strength Rating Upgrade; Hits Key ThresholdInvestors Business Daily • 07/16/20
Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Efficacy Analysis from the Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL® (bempedoic acid) TabletsGlobeNewsWire • 07/01/20
Esperion and Daiichi Sankyo Europe Announce Amendment to License and Commercial Collaboration AgreementGlobeNewsWire • 06/22/20
Esperion Announces Pooled Analysis from Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL™ (Bempedoic Acid) Tablets Presented at the American Diabetes Association 80th Scientific SessionsGlobeNewsWire • 06/14/20
Esperion Confirms NEXLETOL™ (bempedoic acid) Tablets to be Included in Assessment of Non-statin Medicines for Hypercholesterolemia by ICERGlobeNewsWire • 06/12/20
Esperion to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare ConferenceGlobeNewsWire • 06/08/20
Why Is Esperion Therapeutics (ESPR) Down 1.5% Since Last Earnings Report?Zacks Investment Research • 06/05/20
All You Need to Know About Esperion Therapeutics (ESPR) Rating Upgrade to BuyZacks Investment Research • 06/04/20
Esperion Announces Commercial Availability of NEXLIZET™ (bempedoic acid and ezetimibe) Tablets and Ushers in New Era of Oral Combination Medicine for LDL-Cholesterol LoweringGlobeNewsWire • 06/04/20
Esperion Therapeutics' (ESPR) CEO Tim Mayleben on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
Esperion Announces Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of NEXLETOL™ (bempedoic acid) and NEXLIZET™ (bempedoic acid and ezetimibe) Tablets in JapanGlobeNewsWire • 04/20/20